|
|
|
Insider
Information: |
Foletta Mark G |
Relationship: |
EVP & Chief Financial ... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
110,179 |
|
Indirect Shares
|
62,398 |
|
|
Direct
Value |
$1,139,767 |
|
|
Indirect Value
|
$7,947,633 |
|
|
Total
Shares |
172,577 |
|
|
Total
Value |
$9,087,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
1
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
Percentage
Gain/Loss : |
0.7%
|
13.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Financial O... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
DexCom Inc |
DXCM |
Director |
2024-05-22 |
2,973 |
2024-05-22 |
62,398 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2017-12-04 |
81,910 |
2015-08-13 |
0 |
Premium* |
|
AMN Healthcare Services Inc |
AHS |
Director |
2024-04-19 |
10,254 |
2016-04-20 |
0 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
EVP & Chief Financial ... |
2019-05-28 |
15,042 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
144 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-11-30 |
4 |
OE |
$11.13 |
$28,832 |
D/D |
2,500 |
23,830 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-12-29 |
4 |
OE |
$11.95 |
$29,875 |
D/D |
2,500 |
25,094 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-01-31 |
4 |
OE |
$11.95 |
$29,875 |
D/D |
2,500 |
25,094 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Financial OfficerSV |
|
2012-03-01 |
4 |
S |
$17.11 |
$31,585 |
D/D |
(1,846) |
62,490 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-02-28 |
4 |
OE |
$11.95 |
$33,107 |
D/D |
2,500 |
25,728 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-03-30 |
4 |
OE |
$13.25 |
$33,125 |
D/D |
2,500 |
25,742 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-04-30 |
4 |
OE |
$13.25 |
$33,125 |
D/D |
2,500 |
25,742 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-06-29 |
4 |
OE |
$13.25 |
$33,125 |
D/D |
2,500 |
25,742 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-08-31 |
4 |
OE |
$13.25 |
$39,750 |
D/D |
3,000 |
26,242 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-09-28 |
4 |
OE |
$13.25 |
$39,750 |
D/D |
3,000 |
26,242 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2007-07-31 |
4 |
OE |
$13.25 |
$46,375 |
D/D |
3,500 |
26,742 |
0 |
- |
|
FBRX |
Forte Biosciences Inc |
EVP & Chief Financial Officer |
|
2017-04-19 |
4 |
B |
$10.00 |
$50,000 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Financial Officer |
|
2012-02-08 |
4 |
D |
$16.47 |
$51,419 |
D/D |
(3,122) |
54,565 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2017-06-13 |
4 |
S |
$36.71 |
$55,058 |
D/D |
(1,500) |
6,025 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2006-02-15 |
4 |
AS |
$37.70 |
$56,550 |
D/D |
(1,500) |
27,048 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2004-11-30 |
4 |
AS |
$20.35 |
$61,050 |
D/D |
(3,000) |
19,262 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2004-10-29 |
4 |
AS |
$21.05 |
$63,143 |
D/D |
(3,000) |
19,262 |
|
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2017-12-04 |
4 |
A |
$0.89 |
$64,000 |
D/D |
71,910 |
81,910 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2016-12-15 |
4 |
S |
$37.81 |
$68,058 |
D/D |
(1,800) |
3,732 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2004-12-31 |
4 |
AS |
$23.50 |
$70,500 |
D/D |
(3,000) |
19,262 |
|
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2015-08-13 |
4 |
B |
$7.64 |
$76,405 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-08-15 |
4 |
AS |
$41.76 |
$83,520 |
D/D |
(2,000) |
21,788 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
|
2006-05-15 |
4 |
AS |
$42.75 |
$85,500 |
D/D |
(2,000) |
21,788 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
|
2006-01-17 |
4 |
AS |
$43.00 |
$86,000 |
D/D |
(2,000) |
26,498 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
|
2006-06-15 |
4 |
AS |
$43.00 |
$86,000 |
D/D |
(2,000) |
21,788 |
|
- |
|
144 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|